{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:33:16Z","timestamp":1790695996133,"version":"4.1.0"},"reference-count":122,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Iacocca Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The appreciation that cancer growth is promoted by a dynamic tumor microenvironment (TME) has spawned novel approaches to cancer treatment. New therapies include agents that activate quiescent T effector cells and agents that interfere with abnormal neovascularity. Although promising, many experimental therapies targeted at the TME have systemic toxicity. Another approach is to target the TME with greater specificity by taking aim at the tumor necrosis factor receptor 2 (TNFR2) signaling pathway. TNFR2 is an attractive molecular target because it is rarely expressed in normal tissues (thus, has low potential for systemic toxicity) and because it is overexpressed on many types of cancer cells as well as on associated TME components, such as T regulatory cells (Tregs), tumor-associated macrophages, and other cells that facilitate tumor progression and spread. Novel therapies that block TNFR2 signaling show promise in cell culture studies, animal models, and human studies. Novel antibodies have been developed that expressly kill only rapidly proliferating cells expressing newly synthesized TNFR2 protein. This review traces the origins of our understanding of TNFR2\u2019s multifaceted roles in the TME and discusses the therapeutic potential of agents designed to block TNFR2 as the cornerstone of a TME-specific strategy.<\/jats:p>","DOI":"10.3390\/cells11121952","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:45:44Z","timestamp":1655466344000},"page":"1952","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy"],"prefix":"10.3390","volume":"11","author":[{"given":"Hiroyuki","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Fukuoka University Hospital, Fukuoka 814-0180, Japan"},{"name":"Immunobiology Department, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gumpei","family":"Yoshimatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Fukuoka University Hospital, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Louise","family":"Faustman","sequence":"additional","affiliation":[{"name":"Immunobiology Department, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"ref_1","first-page":"224","article-title":"The toxicity and pharmacological action of the nitrogen mustards and certain related compounds","volume":"91","author":"Anslow","year":"1947","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102816","DOI":"10.1016\/j.critrevonc.2019.102816","article-title":"Current opinions in immune checkpoint inhibitors rechallenge in solid cancers","volume":"144","author":"Gobbini","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer immunotherapies targeting the PD-1 signaling pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Jiao","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1470-2045(18)30622-3","article-title":"Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors","volume":"19","author":"Varricchi","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: Long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: Live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: Microenvironment-targeting combinations","volume":"30","author":"Warner","year":"2020","journal-title":"Cell Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2018.210","article-title":"Trial watch: The clinical trial landscape for PD1\/PDL1 immune checkpoint inhibitors","volume":"17","author":"Tang","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","article-title":"Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3389\/fimmu.2018.01170","article-title":"TNF Receptor 2 makes tumor necrosis factor a friend of tumors","volume":"9","author":"Sheng","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1742-4658.2011.08017.x","article-title":"Tumor necrosis factor receptor cross-talk","volume":"278","author":"Naude","year":"2011","journal-title":"FEBS J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2013.00478","article-title":"TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine","volume":"4","author":"Faustman","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.micpath.2004.06.004","article-title":"Tumor necrosis factor-alpha is required for gastritis induced by Helicobacter felis infection in mice","volume":"37","author":"Hasegawa","year":"2004","journal-title":"Microb. Pathog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eaao4910","DOI":"10.1126\/scisignal.aao4910","article-title":"Structural principles of tumor necrosis factor superfamily signaling","volume":"11","author":"Vanamee","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/cdd.2015.109","article-title":"Principles of antibody-mediated TNF receptor activation","volume":"22","author":"Wajant","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0140-6736(92)91446-F","article-title":"TNF alpha in stool as marker of intestinal inflammation","volume":"340","author":"Mendis","year":"1992","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin alpha and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Lauenborg","year":"2015","journal-title":"Oncotarget"},{"key":"ref_23","first-page":"3085","article-title":"Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2\/Akt and ERK signaling pathways","volume":"5","author":"Yang","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1471-4906(03)00166-2","article-title":"A co-evolution perspective of the TNFSF and TNFRSF families in the immune system","volume":"24","author":"Collette","year":"2003","journal-title":"Trends Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","article-title":"TNFR2: A novel target for cancer immunotherapy","volume":"23","author":"Vanamee","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10495-014-1061-5","article-title":"Structural basis of cell apoptosis and necrosis in TNFR signaling","volume":"20","author":"Huang","year":"2015","journal-title":"Apoptosis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3389\/fimmu.2019.02040","article-title":"Targeting regulatory T cells by addressing tumor necrosis factor and its receptors in allogeneic hematopoietic cell transplantation and cancer","volume":"10","author":"Wajant","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.7544915","article-title":"TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40","volume":"269","author":"Rothe","year":"1995","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.cellsig.2014.08.011","article-title":"TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2","volume":"26","author":"Rodriguez","year":"2014","journal-title":"Cell Signal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"ref_31","first-page":"157","article-title":"Variation in serum levels of the soluble TNF receptors among healthy individuals","volume":"11","author":"Aderka","year":"1992","journal-title":"Lymphokine Cytokine Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: Drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/1541-7786.MCR-10-0210","article-title":"Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells","volume":"9","author":"Hamilton","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yexcr.2007.10.005","article-title":"TNF alpha acting on TNFR1 promotes breast cancer growth via p42\/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways","volume":"314","author":"Rivas","year":"2008","journal-title":"Exp. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3892\/ol.2016.5403","article-title":"Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K\/AKT signaling pathway","volume":"1","author":"Zhao","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/onc.2011.567","article-title":"Breaking the \u2018harmony\u2019 of TNF-alpha signaling for cancer treatment","volume":"31","author":"Sasi","year":"2012","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2353\/ajpath.2010.091218","article-title":"Tumor necrosis factor receptor expression and signaling in renal cell carcinoma","volume":"177","author":"Sadler","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"58381","DOI":"10.18632\/oncotarget.11126","article-title":"Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K\/Akt\/mTOR signaling pathway","volume":"7","author":"Feng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/sj.onc.1207317","article-title":"Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development","volume":"23","author":"Arnott","year":"2004","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sasi, S.P., Bae, S., Song, J., Perepletchikov, A., Schneider, D., Carrozza, J., Yan, X., Kishore, R., Enderling, H., and Goukassian, D.A. (2014). Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092373"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gene.2017.12.051","article-title":"Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma","volume":"646","author":"Lan","year":"2018","journal-title":"Gene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1158\/0008-5472.CAN-14-3394","article-title":"Metastasis Suppressors regulate the tumor microenvironment by blocking recruitment of prometastatic tumor-associated macrophages","volume":"75","author":"Frankenberger","year":"2015","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3892\/mmr.2017.6898","article-title":"TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4049\/jimmunol.0903548","article-title":"Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells","volume":"185","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1158\/0008-5472.CAN-14-3173","article-title":"TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases","volume":"75","author":"Ham","year":"2015","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41388-019-1078-x","article-title":"The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-alpha\/IL-33\/ST2L signaling promotes gastric cancer metastasis","volume":"39","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2018.07.001","article-title":"Tumor necrosis factor-alpha promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells","volume":"434","author":"Jing","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2004.07.027","article-title":"Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2","volume":"219","author":"Tanimura","year":"2005","journal-title":"Cancer Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"26323","DOI":"10.18632\/oncotarget.15461","article-title":"Tumor necrosis factor receptor 2\/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e1040215","DOI":"10.1080\/2162402X.2015.1040215","article-title":"Blockade of TNF-alpha signaling benefits cancer therapy by suppressing effector regulatory T cell expansion","volume":"4","author":"Chang","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"24111","DOI":"10.18632\/oncotarget.8125","article-title":"Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clim.2013.07.003","article-title":"Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment","volume":"149","author":"Govindaraj","year":"2013","journal-title":"Clin. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/carcin\/bgt038","article-title":"Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis","volume":"34","author":"Chopra","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1158\/1078-0432.CCR-1053-03","article-title":"Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1","volume":"10","author":"Johrer","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1158\/1078-0432.CCR-13-1576","article-title":"Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients","volume":"20","author":"Govindaraj","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1210\/jc.2004-0127","article-title":"Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts","volume":"89","author":"Deb","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/imt-2018-0156","article-title":"Re-education of macrophages as a therapeutic strategy in cancer","volume":"11","author":"Kowal","year":"2019","journal-title":"Immunotherapy"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/path.4824","article-title":"CAFs and TAMs: Maestros of the tumour microenvironment","volume":"241","author":"Komohara","year":"2017","journal-title":"J. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"103682","DOI":"10.18632\/oncotarget.21771","article-title":"The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation","volume":"8","author":"Dollt","year":"2017","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1101101","article-title":"Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages","volume":"188","author":"Tai","year":"2012","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biomaterials.2017.10.027","article-title":"Molecular mechanism of Gd@C82(OH)22 increasing collagen expression: Implication for encaging tumor","volume":"152","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nm.4448","article-title":"Granulocyte-derived TNFalpha promotes vascular and hematopoietic regeneration in the bone marrow","volume":"24","author":"Bowers","year":"2018","journal-title":"Nat. Med."},{"key":"ref_64","first-page":"2954","article-title":"TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice","volume":"119","author":"Baluk","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"16378","DOI":"10.1038\/s41598-019-52816-z","article-title":"Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer network","volume":"9","author":"Ieda","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1074\/jbc.M109.056523","article-title":"Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction","volume":"285","author":"Takahashi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: Key players in tumor immune escape and angiogenesis","volume":"72","author":"Facciabene","year":"2012","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ni.2849","article-title":"Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells","volume":"15","author":"Mahmud","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/srep03153","article-title":"Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2","volume":"3","author":"Okubo","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fimmu.2018.00573","article-title":"An Autocrine TNFalpha-tumor necrosis factor receptor 2 loop promotes epigenetic effects inducing human treg stability in vitro","volume":"9","author":"Urbano","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"eaan0790","DOI":"10.1126\/scisignal.aan0790","article-title":"Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer","volume":"11","author":"Nie","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"eaaf8608","DOI":"10.1126\/scisignal.aaf8608","article-title":"Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs","volume":"10","author":"Torrey","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/s41375-018-0292-9","article-title":"Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sezary syndrome","volume":"33","author":"Torrey","year":"2019","journal-title":"Leukemia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00262-015-1751-z","article-title":"Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients","volume":"64","author":"Yan","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.4049\/jimmunol.180.10.6467","article-title":"Cutting edge: Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: Applicability to tumor-infiltrating T regulatory cells","volume":"180","author":"Chen","year":"2008","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.4049\/jimmunol.0803482","article-title":"TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.semcancer.2012.01.010","article-title":"Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells","volume":"22","author":"Nagaraj","year":"2012","journal-title":"Semin Cancer Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4049\/jimmunol.1203195","article-title":"Transmembrane TNF-alpha promotes suppressive activities of myeloid-derived suppressor cells via TNFR2","volume":"192","author":"Hu","year":"2014","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.intimp.2016.12.028","article-title":"Transmembrane tumor necrosis factor-alpha promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2","volume":"44","author":"Ba","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2006-06-026385","article-title":"Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"G850","DOI":"10.1152\/ajpgi.00071.2008","article-title":"Signaling pathway via TNF-alpha\/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis","volume":"296","author":"Onizawa","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Suzuki, M., Nagaishi, T., Yamazaki, M., Onizawa, M., Watabe, T., Sakamaki, Y., Ichinose, S., Totsuka, M., Oshima, S., and Okamoto, R. (2014). Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088369"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-20-3175","article-title":"A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP Signaling in hepatic progenitor cells","volume":"81","author":"Meng","year":"2021","journal-title":"Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neo.2020.12.007","article-title":"Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer","volume":"23","author":"He","year":"2021","journal-title":"Neoplasia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell-immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1111\/jcmm.14202","article-title":"Critical role of Lin28-TNFR2 signalling in cardiac stem cell activation and differentiation","volume":"23","author":"Xiang","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1523\/JNEUROSCI.0211-16.2016","article-title":"Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination","volume":"36","author":"Madsen","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m(6)A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1096\/fba.2019-00071","article-title":"Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133(+) cells in clear cell renal carcinoma","volume":"2","author":"Bradley","year":"2020","journal-title":"FASEB Bioadv."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/cbt.2.5.532","article-title":"Apoptotic response to 5-fluorouracil treatment is mediated by reduced polyamines, non-autocrine Fas ligand and induced tumor necrosis factor receptor 2","volume":"2","author":"Zhang","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr3083","article-title":"Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: A study in isogenic resistant tumor cells","volume":"14","author":"Sprowl","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/2326-6066.CIR-21-0690","article-title":"Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma","volume":"10","author":"DeRogatis","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"165.42","DOI":"10.4049\/jimmunol.204.Supp.165.42","article-title":"Targeting TNFR2 to overcome acquired adaptive resistance to immune checkpoint blockade","volume":"204","author":"Mayer","year":"2020","journal-title":"J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/JLB.5MA0420-375RRRRR","article-title":"TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models","volume":"107","author":"Case","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"eaal2328","DOI":"10.1126\/scisignal.aal2328","article-title":"Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer","volume":"10","author":"Chen","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23746","article-title":"Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients","volume":"89","author":"Govindaraj","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/1078155218784762","article-title":"Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case report","volume":"25","author":"Goo","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome","volume":"47","author":"Abate","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-016-2319-2","article-title":"Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma","volume":"131","author":"Ahluwalia","year":"2017","journal-title":"J. Neurooncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/cncr.31537","article-title":"Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer","volume":"124","author":"Xiao","year":"2018","journal-title":"Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3892\/ol.2017.6410","article-title":"Clinical implications of tumor necrosis factor receptor 2 in breast cancer","volume":"14","author":"Yang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2559.2008.03128.x","article-title":"Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: Clinicopathological correlations","volume":"53","author":"Cui","year":"2008","journal-title":"Histopathology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2019.03.013","article-title":"TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes","volume":"209","author":"Ghods","year":"2019","journal-title":"Immunol. Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.humpath.2018.03.027","article-title":"High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma","volume":"80","author":"Liu","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/bjc.2012.172","article-title":"Inflammation marker and risk of pancreatic cancer: A nested case-control study within the EPIC cohort","volume":"106","author":"Grote","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1111\/cas.14198","article-title":"Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer","volume":"110","author":"Hamaguchi","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/bjc.2016.85","article-title":"Soluble tumour necrosis factor receptor type II and survival in colorectal cancer","volume":"114","author":"Babic","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_113","first-page":"609","article-title":"Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer","volume":"47","author":"Dobrzycka","year":"2009","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.18632\/oncotarget.23581","article-title":"Aberrant frequency of TNFR2(+) Treg and related cytokines in patients with CIN and cervical cancer","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"ref_115","first-page":"3125","article-title":"Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer","volume":"16","author":"Gadducci","year":"1996","journal-title":"Anticancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/ijc.25840","article-title":"Tumor necrosis factor (TNF)-alpha, soluble TNF receptors and endometrial cancer risk: The EPIC study","volume":"129","author":"Dossus","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10552-010-9560-3","article-title":"Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: A prospective study","volume":"21","author":"Gu","year":"2010","journal-title":"Cancer Causes Control"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1182\/blood-2013-01-481077","article-title":"A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma","volume":"122","author":"Purdue","year":"2013","journal-title":"Blood"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/JLB.5AB0320-415RRRRR","article-title":"Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity","volume":"107","author":"Yang","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"eaax0720","DOI":"10.1126\/scitranslmed.aax0720","article-title":"Antibody-mediated targeting of TNFR2 activates CD8(+) T cells in mice and promotes antitumor immunity","volume":"11","author":"Tam","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Al-Hatamleh, M.A.I., EARE, Boer, J.C., Ferji, K., Six, J.L., Chen, X., Elkord, E., Plebanski, M., and Mohamud, R. (2019). Synergistic effects of nanomedicine targeting TNFR2 and DNA demethylation inhibitor-an opportunity for cancer treatment. Cells, 9.","DOI":"10.3390\/cells9010033"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat. Genet."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/12\/1952\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:34:01Z","timestamp":1760139241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/12\/1952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":122,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["cells11121952"],"URL":"https:\/\/doi.org\/10.3390\/cells11121952","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}